Jafron attended 56th ERA-EDTA

time :  2019-07-10

During June 13-15, 56th ERA-EDTA was heled in Budapest Hungary. As one of the most influential academic events in the field of international nephrology, ERA-EDTA was highly regarded. This year, nearly ten thousand professionals from all over the world participated in the conference.

1.健帆产品受到海内外专家的关注.jpg

                                                    Jafron products attracted experts’attention

As the leading enterprise in the blood purification area, Jafron had the wonderful appearance with special decorated booth. We communicated with many experts about the application of blood adsorption technology in the field of nephropathy, jointly promote the development and popularization of blood adsorption technology worldwide. Jafron displayed the HA, BS DNA series of products and JF-800A hemoperfusion machine, Future 20 two pumps machine which were favored by experts at home and abroad.

2.jpg

                                         Professor Ronco and Vanholder visited Jafron booth

Recently, Jafron's contribution in the field of blood purification is highly recognized by many top experts in the industry. During the conference, professor Claudio Ronco, Raymond Vanholder visisted Jafron booth, concerned about the overseas development of Jafron, and put forward professional opinions on the application of Jafron blood adsorption technology in the world. Meanwhile, the expert delegation from China is also looking forward to the rapid development and application of Jafron products in the future.

 3.中国专家.jpg

                                                                                                  The expert delegation from China

 At this moment, Jafron’s Original products applied widely in the kidney disease, liver disease, poisoning, rheumatism and immunity and critical diseases, and widely used in more than 40 countries and regions around the world. With the development of Jafron overseas market, the original technology from China will benefit more and more patients around the world.